SCHEMBL9912427

SCHEMBL9912427

COC(=O)CSc1snnc1-c1ccc(C)cc1I

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.56
KMT2A Q03164 2/20 0.56
MEN1 O00255 1/20 0.56
KDM4E B2RXH2 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
HSD17B10 Q99714 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
LMNA P02545 2/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
ALDH1A1 P00352 5/20 0.38
TSHR P16473 2/20 0.38
HPGD P15428 2/20 0.37
POLB P06746 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
MAPK1 P28482 3/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9912429 0.87 MEN1 (0.41) MAPTKMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL9610085 0.86 MAPT (0.65) MAPTKMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL859927 0.74 KMT2A (0.55) MAPTKMT2AMEN1KDM4EHSD17B10
SCHEMBL9610108 0.73 MEN1 (0.48) MAPTKMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL846103 0.68 MAPT (0.46) MAPTKMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL15517362 0.62 HSD17B10 (0.50) MAPTKMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL11732818 0.61 MAPT (0.45) MAPTKMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL13949073 0.61 ALDH1A1 (0.53) MAPTKMT2AKDM4ESMN1; SMN2HSD17B10
SCHEMBL10508192 0.59 KDM4E (0.50) MAPTKMT2AKDM4ESMN1; SMN2HSD17B10
SCHEMBL16154469 0.58 CYP2A6 (0.43) MAPTSMN1; SMN2HSD17B10ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8198458-B2 Non-nucleoside reverse transcriptase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-12 US disclosed